Clinical trial Recruiting at 1 site Interventional Ages 22 and up

Long-term effects of epidural stimulation for spinal cord injury recovery

Official title: Epidural Stimulation After Neurologic Damage: Long-Term Outcomes

Run by University of Minnesota · NCT05705453 · Data updated 2026-11-12

This study tests if long-term spinal cord stimulation can help people with chronic spinal cord injuries regain voluntary movement over ten years.

More SCI - Spinal Cord Injury trials

Quick facts

Study typeInterventional
Ages22 Years and up
SexAll
Enrollment50 (estimated)
SponsorUniversity of Minnesota
Academic / other
Locations1 site (Minneapolis, Minnesota)
StatusRecruiting
StartedMay 11, 2023
Main results expectedApril 1, 2033
Study endsApril 1, 2034
Registry record updatedApril 8, 2026
Trial IDNCT05705453 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 22 and older with stable spinal cord injuries below the C5 level and who have a functional implanted spinal cord stimulator.

Probably not a fit

Patients who are dependent on opioids for pain management or have conditions that prevent full participation in rehabilitation may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the long-term effects of chronic spinal cord stimulation on restoring voluntary movement in patients with chronic spinal cord injuries. Participants will be enrolled for a decade and will attend assessments biannually in Minneapolis, where they will undergo various programming settings of their spinal cord stimulators. The goal is to determine the efficacy of epidural stimulation in improving motor function over time.

Why it matters

Potential benefit: If successful, this could significantly enhance mobility and quality of life for individuals with chronic spinal cord injuries.

How similar studies have gone: Other studies have shown promising results with spinal cord stimulation, indicating potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 22 years of age or older
* Able to undergo the informed consent process
* Stable spinal cord injury
* International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI) neurologic level of injury below C5
* No ventilator dependency within the last year
* American Spinal Injury Association (AISA) imparement scale"A" or "B" in the absence of spinal cord stimulation
* Medically stable in the judgment of the Principal investigator
* Greater than 1 year since initial injury and at least 6 months from any required spinal instrumentation and 2 months from spinal cord stimulator surgery
* Has an existing and functional implanted spinal cord stimulator system that is FDA approved and can be corroborated by hospital documentation
* Spinal imaging of the stimulator system

Exclusion Criteria:

* Current and anticipated need for opioid pain medications or pain that would prevent full participation in the rehabilitation program in the judgment of the principal investigator
* Use of botulinum toxin (Botox) injections in the previous six months
* Clinically significant mental illness in the judgment of the principal investigator
* Other conditions or medications that would make the subject unable to participate in testing/rehabilitation in the judgment of the principal investigator
* Nonfunctional spinal cord stimulator or near end-of-life, determined by the PI
* Current Pregnancy
* Current pain relief from the spinal cord stimulator if the indication for implantation was for management of chronic pain.

Where it's running

  • Hennepin County Medical Center
    Minneapolis, Minnesota, United States
    Recruiting

Study contacts

  • Principal investigator: David Darrow, MD — University of Minnesota
  • Study coordinator: Study Coordinator
  • Email: estand@umn.edu
  • Phone: 612-873-9113

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.